Rate My Professor Dhaval Joshi

Joshi's research focuses on pharmacology, with interests in dermatology and diabetes mellitus as noted on his academic profiles. He has contributed to multiple peer-reviewed publications addressing clinical pharmacy challenges, adverse drug reactions, and therapeutic outcomes. Key works include "Assessment of Causality, Preventability and Severity of Cutaneous Adverse Drug Reactions: A Prospective Observational Study" (2021), "Prospective study on comparison of efficacy of topical anti-fungal agents clotrimazole 1% and sertaconazole 2% in treatment of tinea cruris," "An observational study to monitor and report radiation-related adverse events by a clinical pharmacist to achieve a better therapeutic outcome and suggest preventive measures in a tertiary care teaching hospital" (2021), "Impact of Clinical Pharmacist-Led Discharge Counseling" (2025), "A study of awareness of generic drugs amongst residents and intern doctors in a tertiary care hospital in Surat city," and "Incidence of Adverse Drug Reactions Among Elderly Patients: A systematic review and meta-analysis" (2026). With 19 publications on ResearchGate garnering 33 citations, his research emphasizes practical applications in pharmacovigilance, antifungal efficacy, and patient safety in clinical settings. Joshi's multifaceted role enhances academic training and research output at the institute.